| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |